Literature DB >> 24726835

Emotional regulatory function of receptor interacting protein 140 revealed in the ventromedial hypothalamus.

S Flaisher-Grinberg1, H C Tsai2, X Feng1, L N Wei3.   

Abstract

Receptor-interacting protein (RIP140) is a transcription co-regulator highly expressed in macrophages to regulate inflammatory and metabolic processes. However, its implication in neurological, cognitive and emotional conditions, and the cellular systems relevant to its biological activity within the central nervous system are currently less clear. A transgenic mouse line with macrophage-specific knockdown of RIP140 was generated (MΦRIPKD mice) and brain-region specific RIP140 knockdown efficiency evaluated. Mice were subjected to a battery of tests, designed to evaluate multiple behavioral domains at naïve or following site-specific RIP140 re-expression. Gene expression analysis assessed TNF-α, IL-1β, TGF-1β, IL1-RA and neuropeptide Y (NPY) expression, and in vitro studies examined the effects of macrophage's RIP140 on astrocytes' NPY production. We found that RIP140 expression was dramatically reduced in macrophages within the ventromedial hypothalamus (VMH) and the cingulate cortex of MΦRIPKD mice. These animals exhibited increased anxiety- and depressive-like behaviors. VMH-targeted RIP140 re-expression in MΦRIPKD mice reversed its depressive- but not its anxiety-like phenotype. Analysis of specific neurochemical changes revealed reduced astrocytic-NPY expression within the hypothalamus of MΦRIPKD mice, and in vitro analysis confirmed that conditioned medium of RIP140-silnenced macrophage culture could no longer stimulate NPY production from astrocytes. The current study revealed an emotional regulatory function of macrophage-derived RIP140 in the VMH, and secondary dysregulation of NPY within hypothalamic astrocyte population, which might be associated with the observed behavioral phenotype of MΦRIPKD mice. This study highlights RIP140 as a novel target for the development of potential therapeutic and intervention strategies for emotional regulation disorders.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Depression; Immune system; NPY; RIP140; Ventromedial hypothalamus

Mesh:

Substances:

Year:  2014        PMID: 24726835      PMCID: PMC4102625          DOI: 10.1016/j.bbi.2014.03.019

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  49 in total

Review 1.  The NPY system in stress, anxiety and depression.

Authors:  Markus Heilig
Journal:  Neuropeptides       Date:  2004-08       Impact factor: 3.286

Review 2.  Transcriptional dysregulation in Down syndrome: predictions for altered protein complex stoichiometries and post-translational modifications, and consequences for learning/behavior genes ELK, CREB, and the estrogen and glucocorticoid receptors.

Authors:  Katheleen Gardiner
Journal:  Behav Genet       Date:  2006-02-24       Impact factor: 2.805

3.  Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation.

Authors:  Divya Vats; Lata Mukundan; Justin I Odegaard; Lina Zhang; Kristi L Smith; Christine R Morel; Roger A Wagner; David R Greaves; Peter J Murray; Ajay Chawla
Journal:  Cell Metab       Date:  2006-07       Impact factor: 27.287

4.  Tissue-specific and cell type-specific RNA interference in vivo.

Authors:  Manjeet K Rao; Miles F Wilkinson
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

5.  Characterization of receptor-interacting protein RIP140 in the regulation of SF-1 responsive target genes.

Authors:  Gunnar Mellgren; Bente Børud; Tuyen Hoang; Olav Erich Yri; Cathrine Fladeby; Ernst Asbjørn Lien; Johan Lund
Journal:  Mol Cell Endocrinol       Date:  2003-05-30       Impact factor: 4.102

6.  Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin.

Authors:  Alexandra Wigger; Mar M Sánchez; Kenneth C Mathys; Karl Ebner; Elisabeth Frank; Dong Liu; Adelheid Kresse; Inga D Neumann; Florian Holsboer; Paul M Plotsky; Rainer Landgraf
Journal:  Neuropsychopharmacology       Date:  2004-01       Impact factor: 7.853

7.  Neurochemical characteristics of the ventromedial hypothalamus in mediating the antiaversive effects of anxiolytics in different models of anxiety.

Authors:  A N Talalaenko; D V Pankrat'ev; N V Goncharenko
Journal:  Neurosci Behav Physiol       Date:  2003-03

8.  Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin.

Authors:  D R Rubinow; G L Peck; K M Squillace; G G Gantt
Journal:  J Am Acad Dermatol       Date:  1987-07       Impact factor: 11.527

9.  [Expression profile of receptor-interacting protein 140 in the brain: experiment with prenatal and postnatal mice].

Authors:  Xiao-Rui Zhang; Chao-Mei Zeng; Jun-Bao DU; Rong Liang; Li-Jun Yang; Wei-Dong Yu; Jing-Zhu Guo
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2007-11-27

Review 10.  Dual role of inflammation in CNS disease.

Authors:  Reinhard Hohlfeld; Martin Kerschensteiner; Edgar Meinl
Journal:  Neurology       Date:  2007-05-29       Impact factor: 9.910

View more
  8 in total

1.  Retinoic Acid Induces Ubiquitination-Resistant RIP140/LSD1 Complex to Fine-Tune Pax6 Gene in Neuronal Differentiation.

Authors:  Cheng-Ying Wu; Shawna D Persaud; Li-Na Wei
Journal:  Stem Cells       Date:  2015-10-09       Impact factor: 6.277

2.  Behavioral stress reduces RIP140 expression in astrocyte and increases brain lipid accumulation.

Authors:  Xudong Feng; Yu-Lung Lin; Li-Na Wei
Journal:  Brain Behav Immun       Date:  2015-02-16       Impact factor: 7.217

3.  An Integrated Bioinformatics Analysis of the Potential Regulatory Effects of miR-21 on T-cell Related Target Genes in Multiple Sclerosis.

Authors:  Mostafa Manian; Ehsan Sohrabi; Nahid Eskandari; Mohammad-Ali Assarehzadegan; Gordon A Ferns; Mitra Nourbakhsh; Mir Hadi Jazayeri; Reza Nedaeinia
Journal:  Avicenna J Med Biotechnol       Date:  2021 Jul-Sep

4.  Temporal and Site-Specific Changes in Central Neuroimmune Factors During Rapid Weight Gain After Ovariectomy in Rats.

Authors:  Kathleen S Curtis; Kelly McCracken; Enith Espinosa; Johnson Ong; Daniel J Buck; Randall L Davis
Journal:  Neurochem Res       Date:  2018-07-20       Impact factor: 3.996

5.  Suppressing Receptor-Interacting Protein 140: a New Sight for Salidroside to Treat Cerebral Ischemia.

Authors:  Tong Chen; Zhanqiang Ma; Lingpeng Zhu; Wenjiao Jiang; Tingting Wei; Rui Zhou; Fen Luo; Kai Zhang; Qiang Fu; Chunhua Ma; Tianhua Yan
Journal:  Mol Neurobiol       Date:  2015-11-13       Impact factor: 5.590

6.  Expression and Regulatory Network Analysis of miR-140-3p, a New Potential Serum Biomarker for Autism Spectrum Disorder.

Authors:  Matilde Cirnigliaro; Cristina Barbagallo; Mariangela Gulisano; Carla N Domini; Rita Barone; Davide Barbagallo; Marco Ragusa; Cinzia Di Pietro; Renata Rizzo; Michele Purrello
Journal:  Front Mol Neurosci       Date:  2017-08-10       Impact factor: 5.639

7.  Receptor-interacting protein 140 as a co-repressor of Heat Shock Factor 1 regulates neuronal stress response.

Authors:  Yu-Lung Lin; Hong-Chieh Tsai; Pei-Yao Liu; Michael Benneyworth; Li-Na Wei
Journal:  Cell Death Dis       Date:  2017-12-12       Impact factor: 8.469

8.  Receptor-Interacting Protein 140 Enhanced Temozolomide-Induced Cellular Apoptosis Through Regulation of E2F1 in Human Glioma Cell Lines.

Authors:  Hong-Chieh Tsai; Kuo-Chen Wei; Pin-Yuan Chen; Chiung-Yin Huang; Ko-Ting Chen; Ya-Jui Lin; Hsiao-Wei Cheng; Chun-Hao Huang; Hsiang-Tsui Wang
Journal:  Neuromolecular Med       Date:  2021-06-01       Impact factor: 3.843

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.